Autopsy report · NCT00853229

Pregabalin for the Treatment of Vulvodynia

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Not feasible due to low accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 2 months before it stopped.
16 participants enrolled.
Results were posted on the registry 4 years 1 month after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: The Cleveland Clinic
Sponsor type: University, hospital or other
Conditions: Vulvodynia; Vulvar Vestibulitis
Interventions: pregabalin
Participants: 16
Sites: 1
Countries: United States

Trials that died the same way

Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma
“Low Accrual” (67% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.